Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Uta Merle

Showing results (181-190 of 188) with videos related to

Pageof 19
Sort By:
You have reached the last page of results.This site can display upto 188 results.
Journal of Clinical Immunology|May 5, 2022
Early and Rapid Identification of COVID-19 Patients with Neutralizing Type I Interferon Auto-antibodiesBengisu Akbil, Tim Meyer, Paula Stubbemann, et al.
Frontiers in Immunology|July 24, 2023
Five-year follow-up of a phase I trial of donor-derived modified immune cell infusion in kidney transplantationMatthias Schaier, Christian Morath, Lei Wang, et al.
JHEP Reports : Innovation in Hepatology|April 7, 2023
Treating hepatitis D with bulevirtide - Real-world experience from 114 patientsChristopher Dietz-Fricke, Frank Tacke, Caroline Zöllner, et al.
Infection|August 16, 2024
Role and benefits of infectious diseases specialists in the COVID-19 pandemic: Multilevel analysis of care provision in German hospitals using data from the Lean European Open Survey on SARS-CoV-2 infected patients (LEOSS) cohortLene T Tscharntke, Norma Jung, Frank Hanses, et al.
Journal of Hepatology|January 10, 2025
Real-world effectiveness and safety of bulevirtide monotherapy for up to 96 weeks in patients with HDV-related cirrhosisElisabetta Degasperi, Maria Paola Anolli, Mathias Jachs, et al.
Nature Cancer|December 29, 2022
Anti-SARS-CoV-2 antibody-containing plasma improves outcome in patients with hematologic or solid cancer and severe COVID-19: a randomized clinical trialClaudia M Denkinger, Maike Janssen, Ulrike Schäkel, et al.
Critical Care (London, England)|October 30, 2025
Therapeutic plasma exchange in amatoxin associated acute liver failure-results from the multi-center Amanita-PEX studyKlaus Stahl, Bahar Nalbant, Thorben Pape, et al.
Infection|July 11, 2023
Analysis of acute COVID-19 including chronic morbidity: protocol for the deep phenotyping National Pandemic Cohort Network in Germany (NAPKON-HAP)Fridolin Steinbeis, Charlotte Thibeault, Sarah Steinbrecher, et al.
Pageof 19

Showing results (181-190 of 188) with videos related to

Sort By:
Pageof 19
You have reached the last page of results.This site can display upto 188 results.
Journal of Clinical Immunology|May 5, 2022
Early and Rapid Identification of COVID-19 Patients with Neutralizing Type I Interferon Auto-antibodiesBengisu Akbil, Tim Meyer, Paula Stubbemann, et al.
Frontiers in Immunology|July 24, 2023
Five-year follow-up of a phase I trial of donor-derived modified immune cell infusion in kidney transplantationMatthias Schaier, Christian Morath, Lei Wang, et al.
JHEP Reports : Innovation in Hepatology|April 7, 2023
Treating hepatitis D with bulevirtide - Real-world experience from 114 patientsChristopher Dietz-Fricke, Frank Tacke, Caroline Zöllner, et al.
Infection|August 16, 2024
Role and benefits of infectious diseases specialists in the COVID-19 pandemic: Multilevel analysis of care provision in German hospitals using data from the Lean European Open Survey on SARS-CoV-2 infected patients (LEOSS) cohortLene T Tscharntke, Norma Jung, Frank Hanses, et al.
Journal of Hepatology|January 10, 2025
Real-world effectiveness and safety of bulevirtide monotherapy for up to 96 weeks in patients with HDV-related cirrhosisElisabetta Degasperi, Maria Paola Anolli, Mathias Jachs, et al.
Nature Cancer|December 29, 2022
Anti-SARS-CoV-2 antibody-containing plasma improves outcome in patients with hematologic or solid cancer and severe COVID-19: a randomized clinical trialClaudia M Denkinger, Maike Janssen, Ulrike Schäkel, et al.
Critical Care (London, England)|October 30, 2025
Therapeutic plasma exchange in amatoxin associated acute liver failure-results from the multi-center Amanita-PEX studyKlaus Stahl, Bahar Nalbant, Thorben Pape, et al.
Infection|July 11, 2023
Analysis of acute COVID-19 including chronic morbidity: protocol for the deep phenotyping National Pandemic Cohort Network in Germany (NAPKON-HAP)Fridolin Steinbeis, Charlotte Thibeault, Sarah Steinbrecher, et al.
Pageof 19